Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities.
about
Antiretroviral pharmacology in mucosal tissuesDevelopment of HIV-1 rectal-specific microbicides and colonic tissue evaluationSeminal plasma induces inflammation and enhances HIV-1 replication in human cervical tissue explants.Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative womenA Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).MIV-150/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model.Pharmacokinetics of antiretrovirals in mucosal tissueThe Molecular Characterization of Intestinal Explant HIV Infection Using Polymerase Chain Reaction-Based Techniques.Pharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 PreventionMIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection.The development of rectal microbicides for HIV prevention.An ex vivo Model of HIV-1 Infection in Human Lymphoid Tissue and Cervico-vaginal Tissue.Cryopreservation of human mucosal tissues
P2860
Q27014675-AB706D87-FC52-4547-9D6C-C78A69E35EE2Q28540761-65D2B4EB-72BC-4FA7-85F5-FE5E91A88B16Q33390855-D657B796-F4C1-48A8-9196-5E4C832B10AEQ33751697-C06A3EA2-F0BF-4783-B669-9EF0999BDECDQ35571216-4D34CC12-00DA-433B-9EC5-6336EA8A5511Q35746218-B5B8A046-8D5A-42A2-8190-A0417E8C3C2DQ35838594-8B84D7D8-92F7-43FA-9A45-3725108CE1FDQ36078433-F87E3612-6868-426F-B4A3-C64E7EF54CE4Q36143276-823E6434-2DD1-41D2-B24C-698F1CBC6F94Q37713059-F604CC8E-848E-41A8-ABE0-76D4529EFC53Q38165222-8C2AB0C0-BC32-4E6F-95CF-806F6B527301Q41902559-916054CA-E66C-41AF-A83D-1D96B1E1A0E5Q57091685-495917B2-0CD2-4F4D-98B2-2EEEFA1D87F3
P2860
Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@ast
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@en
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@nl
type
label
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@ast
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@en
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@nl
prefLabel
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@ast
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@en
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@nl
P2860
P1476
Use of human mucosal tissue to ...... e HIV-1 prevention modalities.
@en
P2093
Charlene S Dezzutti
Florian Hladik
P2860
P2888
P356
10.1007/S11904-012-0148-2
P577
2013-03-01T00:00:00Z